Sio Gene Therapies Inc (SIOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2022 | 03-2021 | 03-2020 | 03-2019 | 03-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -71,887 | -32,425 | -72,628 | -129,065 | -221,573 |
| Depreciation Amortization | 666 | 2,466 | 1,477 | 2,450 | 3,083 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 2,709 |
| Accounts payable and accrued liabilities | 2,643 | -3,071 | 2,710 | -2,251 | -4,602 |
| Other Working Capital | 3,443 | -10,340 | -4,887 | -19,083 | -6,217 |
| Other Operating Activity | 4,789 | -3,219 | 5,855 | 13,742 | 36,252 |
| Operating Cash Flow | $-60,346 | $-46,589 | $-67,473 | $-134,207 | $-190,348 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -695 | -398 | -255 | -202 | -4,284 |
| Sale Of Investment | 4,343 | 12,784 | N/A | N/A | N/A |
| Investing Cash Flow | $3,648 | $12,386 | $-255 | $-202 | $-4,284 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -15,731 | -29,563 | -9,707 | N/A |
| Common Stock Issued | 1,441 | 89,231 | 70,896 | 335 | 1,557 |
| Other Financing Activity | 0 | 121 | 148 | 96,443 | 134,839 |
| Financing Cash Flow | $1,441 | $73,621 | $41,481 | $87,071 | $136,396 |
| Beginning Cash Position | 120,170 | 80,752 | 106,999 | 154,337 | 212,573 |
| End Cash Position | 64,913 | 120,170 | 80,752 | 106,999 | 154,337 |
| Net Cash Flow | $-55,257 | $39,418 | $-26,247 | $-47,338 | $-58,236 |
| Free Cash Flow | |||||
| Operating Cash Flow | -60,346 | -46,589 | -67,473 | -134,207 | -190,348 |
| Capital Expenditure | -695 | -398 | -255 | -202 | -4,284 |
| Free Cash Flow | -61,041 | -46,987 | -67,728 | -134,409 | -194,632 |